Wall Street Breakfast cover image

Wegovy without the needle sparks Novo surge

Wall Street Breakfast

00:00

FDA Clears Wegovy Oral Pill

Julie Morgan reports FDA approval of oral semaglutide for obesity and OASIS-4 trial results.

Play episode from 00:24
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app